Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System

Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用

基本信息

项目摘要

ABSTRACT The importance of placental and decidual secreted factors as mediators of the immunological adjustments needed to accommodate the genetically different mother and fetus during hemochorial pregnancies is well recognized. Galectins are a family of lectins with intracellular and extracellular functions. Secreted galectins bind to N-acetyllactosamine (LacNAc) and form lattices between glycoproteins on the surface of cells and between cells, promoting a plethora of biological activities including regulation of the adaptive and innate immune response. Members of the galectin family exhibit notable differences in carbohydrate specificity and affinity resulting in different functions. Recently, Galectin-9 (Gal-9), which is expressed at the maternal fetal- interface, has been suggested to play a role in maternal T-cell tolerance by binding to its receptors which include among others T cell immunoglobulin and mucin-domain containing-3 (Tim-3) and CD44. On the other hand, Gal-9 has been reported to induce the secretion of pro-inflammatory cytokines by myeloid cells. Recently, we found that Pregnancy-specific glycoprotein 1(PSG1), which is secreted by placental trophoblasts at increasing concentration as pregnancy progresses, binds to Gal-9. PSG1 binds to Gal-9 with high affinity and the interaction is glycan-mediated. Importantly, the concentration of PSG1 is lower than normal in some pregnancy complications including pre-eclampsia. Activation of the innate immune system has been proposed to contribute to trophoblast invasion in the early decidua and to parturition, however it is also associated with adverse pregnancy outcomes when it occurs in the second and third trimesters. Therefore, the temporal and spatial aspects of reducing inflammation during pregnancy represent a complex and essential process for pregnancy success. We propose that the newly found interaction between Gal-9 and PSG1 contributes to the qualitative differences in the immune response required for pregnancy success and that besides their previously identified individual functions, the interplay between these two proteins plays an important role in the modulation of immune cells. Therefore we propose to carry out the following Specific Aims: (1) Analyze the binding of native and recombinant PSG1 to the N-terminal and C-terminal carbohydrate recognition domains of Gal-9. (2) Determine the individual and combined effects of PSG1 and Gal-9 or the individual Gal-9 CRDs on the phenotype and secretion of cytokines by monocytes and decidual macrophages. (3) Determine the effect of individual and combined treatment of PSG1 and Gal-9 in human CD4+ T-cell apoptosis and frequency of CD4+ FoxP3+ T-regulatory cells.
抽象的 作为免疫学的介体的胎盘和决定型分泌因素的重要性 需要调整以适应遗传上不同的母亲和胎儿 良好的妊娠知名度很高。 letectin是一个具有细胞内和的凝集素家族 细胞外功能。分泌的半乳肠蛋白结合N-乙酰乳糖胺(LACNAC)并形成晶格 在细胞表面和细胞之间的糖蛋白之间,促进了很多 生物学活动,包括调节适应性和先天免疫反应。成员 甲状腺素家族的碳水化合物特异性和亲和力的差异很明显 在不同的功能中。最近,Galectin-9(GAL-9),在母亲胎儿表达 界面已被建议通过结合其受体在母体T细胞的耐受性中发挥作用 其中包括T细胞免疫球蛋白和含有-3(TIM-3)和 CD44。另一方面,据报道GAL-9诱导促炎的分泌 髓样细胞的细胞因子。最近,我们发现妊娠特异性糖蛋白1(PSG1), 随着妊娠的进展,胎盘滋养细胞分泌,浓度越来越大, 结合Gal-9。 PSG1与高亲和力的GAL-9结合,相互作用是聚糖介导的。 重要的是,在某些妊娠并发症中,PSG1的浓度低于正常 包括先兆子痫。 已经提出了先天免疫系统的激活,以促进滋养细胞 在早期的deciDua和分娩中的入侵,但也与不利有关 妊娠结局发生在第二和第三个三物质中。因此,时间 减少怀孕期间炎症的空间方面代表了一个复杂而必不可少的 怀孕成功的过程。我们建议新发现的Gal-9和 PSG1导致怀孕所需的免疫反应的定性差异 成功,除了他们先前确定的个人功能外, 这两种蛋白质在免疫细胞的调节中起重要作用。因此我们 建议执行以下特定目的:(1)分析天然和重组的结合 pSG1至GAL-9的N末端和C末端碳水化合物识别域。 (2)确定 PSG1和GAL-9的个体和组合效应或单个GAL-9 CRD对 单核细胞和决结巨噬细胞对细胞因子的表型和分泌。 (3)确定 PSG1和GAL-9在人CD4+ T细胞中的单个和联合处理的影响 CD4+ FOXP3+ T调节细胞的凋亡和频率。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Medawar's PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation.
  • DOI:
    10.3389/fimmu.2021.784473
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Menkhorst E;Than NG;Jeschke U;Barrientos G;Szereday L;Dveksler G;Blois SM
  • 通讯作者:
    Blois SM
Kathryn V. Holmes: A Career of Contributions to the Coronavirus Field.
  • DOI:
    10.3390/v14071573
  • 发表时间:
    2022-07-20
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gabriela S Dveksler其他文献

Gabriela S Dveksler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gabriela S Dveksler', 18)}}的其他基金

Not all members of the pregnancy-specific glycoprotein family are created equal
妊娠特异性糖蛋白家族的所有成员并非生而平等
  • 批准号:
    10349979
  • 财政年份:
    2022
  • 资助金额:
    $ 22.87万
  • 项目类别:
Not all members of the pregnancy-specific glycoprotein family are created equal
妊娠特异性糖蛋白家族的所有成员并非生而平等
  • 批准号:
    10615689
  • 财政年份:
    2022
  • 资助金额:
    $ 22.87万
  • 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
  • 批准号:
    10302501
  • 财政年份:
    2021
  • 资助金额:
    $ 22.87万
  • 项目类别:
Therapeutic potential of PSG1 administration in GVHD
PSG1 给药在 GVHD 中的治疗潜力
  • 批准号:
    9111289
  • 财政年份:
    2016
  • 资助金额:
    $ 22.87万
  • 项目类别:
Pregnancy specific glycoprotein 1 activates transforming growth factor beta
妊娠特异性糖蛋白 1 激活转化生长因子 β
  • 批准号:
    8533727
  • 财政年份:
    2012
  • 资助金额:
    $ 22.87万
  • 项目类别:
Pregnancy specific glycoprotein 1 activates transforming growth factor beta
妊娠特异性糖蛋白 1 激活转化生长因子 β
  • 批准号:
    8359204
  • 财政年份:
    2012
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6688455
  • 财政年份:
    2002
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6823250
  • 财政年份:
    2002
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6580154
  • 财政年份:
    2002
  • 资助金额:
    $ 22.87万
  • 项目类别:
Immunomodulation by Pregnancy Specific Glycoprotein 17
妊娠特异性糖蛋白 17 的免疫调节
  • 批准号:
    6982814
  • 财政年份:
    2002
  • 资助金额:
    $ 22.87万
  • 项目类别:

相似国自然基金

基于移植后急性移植物抗宿主病智能预警的关键算法与应用研究
  • 批准号:
    62306340
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
联合应用Nifuroxazide与SAT05f对急性移植物抗宿主病的防治作用及机制研究
  • 批准号:
    81300442
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mechanisms and consequences of T cell inflammasome activation in Graft-Versus Host Disease
移植物抗宿主病中 T 细胞炎性体激活的机制和后果
  • 批准号:
    10684330
  • 财政年份:
    2022
  • 资助金额:
    $ 22.87万
  • 项目类别:
Targeting PIM-2 Kinase for Improving Cancer Immunotherapy
靶向 PIM-2 激酶以改善癌症免疫治疗
  • 批准号:
    10559633
  • 财政年份:
    2022
  • 资助金额:
    $ 22.87万
  • 项目类别:
Mechanisms and consequences of T cell inflammasome activation in Graft-Versus Host Disease
移植物抗宿主病中 T 细胞炎性体激活的机制和后果
  • 批准号:
    10511777
  • 财政年份:
    2022
  • 资助金额:
    $ 22.87万
  • 项目类别:
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GVT) Responses
Galectin-3 对调节移植物抗宿主病 (GvHD) 和移植物抗肿瘤 (GVT) 反应的影响
  • 批准号:
    10598800
  • 财政年份:
    2022
  • 资助金额:
    $ 22.87万
  • 项目类别:
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GVT) Responses
Galectin-3 对调节移植物抗宿主病 (GvHD) 和移植物抗肿瘤 (GVT) 反应的影响
  • 批准号:
    10619457
  • 财政年份:
    2022
  • 资助金额:
    $ 22.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了